Hospital Access Patient Assistance Program

This program allows eligible hospitals to receive free medications to give to qualified outpatients directly.

Hospitals can apply for this program if they’re currently enrolled in the 340B Drug Pricing Program, which requires drug manufacturers to provide outpatient medications at reduced prices. To apply, hospitals must also be classified as a Disproportionate Share Hospital (a hospital that treats patients who don’t have insurance or aren’t eligible for other health care coverage).

Hospitals that participate in this program are required to sign a contract and agree to on-site assessments.

Apply for the Program

The program includes these medications:

EDURANT®
(rilpivirine) Tablets

INTELENCE®
(etravirine) Tablets

INVEGA® †
(paliperidone) Extended-Release Tablets

INVOKAMET® †
(canagliflozin/metformin HCI) Tablets

INVOKAMET® XR® †
(canagliflozin/metformin HCI) Tablets

INVOKANA®
(canagliflozin) Tablets

PREZCOBIX®
(darunavir 800mg/cobicistat 150mg) Tablets

PREZISTA®
(darunavir) Tablets

RISPERDAL® †
(risperidone) Tablets/Oral Solution

TOPAMAX®
(topiramate) Tablets

XARELTO® †
(rivaroxaban) Tablets

† Please see full U.S. prescribing information, including Black Box warning for: INVOKAMET™, INVOKAMET® XR®, INVOKANA®, PROCRIT®, RISPERDAL®, XARELTO®